Basit öğe kaydını göster

dc.contributor.authorErgül D.F.
dc.contributor.authorBoran M.
dc.date.accessioned2024-03-12T19:35:52Z
dc.date.available2024-03-12T19:35:52Z
dc.date.issued2022
dc.identifier.issn13094483
dc.identifier.urihttps://doi.org/10.52142/omujecm.39.2.51
dc.identifier.urihttps://hdl.handle.net/20.500.12450/3011
dc.description.abstractThe recent global outbreak of coronavirus disease-19, also known as COVID-19, has infected more than 142 million people worldwide, causing more than 3 million deaths. It has been shown that up to 40% of hospitalized COVID-19 patients may develop ARDS. Although not proven, anti-inflammatory and anti-cytokine treatments are recommended to suppress the cytokine storm that develops in the early stages of the disease.In this case report, a case of pulmonary aspergillus developed as a complication of treatment for ARDS caused by covid 19 in a 50-year-old male patient will be presented in the light of current literature. © 2022 Ondokuz Mayis Universitesi. All rights reserved.en_US
dc.description.sponsorshipDURSUN FIRAT ERGÜL-2021-06-02T11_51_11en_US
dc.description.sponsorshipThe patient provided informed consent for the publication of this case. In accordance with the provisions of the Ministry of Health of the Republic of Turkey, the ethics committee of the Ministry of Health was applied and approval was obtained with the number DURSUN FIRAT ERGÜL-2021-06-02T11_51_11. Attached is the e-mail printout showing that it was accepted.en_US
dc.language.isoengen_US
dc.publisherOndokuz Mayis Universitesien_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectacute respiratory distress syndromeen_US
dc.subjectcovid-19-associated pulmonary aspergillosisen_US
dc.subjectpulmonary aspergillosisen_US
dc.subjectsteroid treatmenten_US
dc.subjectanakinraen_US
dc.subjectbudesonideen_US
dc.subjectC reactive proteinen_US
dc.subjectenoxaparinen_US
dc.subjectferritinen_US
dc.subjectfibrinogenen_US
dc.subjectlactic aciden_US
dc.subjectlansoprazoleen_US
dc.subjectmethylprednisoloneen_US
dc.subjectmidazolamen_US
dc.subjectmoxifloxacinen_US
dc.subjectoxygenen_US
dc.subjectpiperacillin plus tazobactamen_US
dc.subjectprocalcitoninen_US
dc.subjectrocuroniumen_US
dc.subjectvoriconazoleen_US
dc.subjectadulten_US
dc.subjectadult respiratory distress syndromeen_US
dc.subjectantibiotic therapyen_US
dc.subjectArticleen_US
dc.subjectasthmaen_US
dc.subjectatelectasisen_US
dc.subjectblood pressureen_US
dc.subjectbreathing rateen_US
dc.subjectbronchoscopyen_US
dc.subjectcarbon dioxide tensionen_US
dc.subjectcase reporten_US
dc.subjectclinical articleen_US
dc.subjectcomputer assisted tomographyen_US
dc.subjectcoronavirus disease 2019en_US
dc.subjectextubationen_US
dc.subjectfeveren_US
dc.subjectfollow upen_US
dc.subjectGlasgow coma scaleen_US
dc.subjecthigh flow nasal cannula therapyen_US
dc.subjecthospitalizationen_US
dc.subjecthumanen_US
dc.subjectintubationen_US
dc.subjectlaboratory testen_US
dc.subjectlavage fluiden_US
dc.subjectleft ventricular apexen_US
dc.subjectleukocyte counten_US
dc.subjectlung aspergillosisen_US
dc.subjectlymphocyte counten_US
dc.subjectmaleen_US
dc.subjectmedical historyen_US
dc.subjectmiddle ageden_US
dc.subjectneutrophil counten_US
dc.subjectnoninvasive ventilationen_US
dc.subjectplatelet counten_US
dc.subjectpneumothoraxen_US
dc.subjectpolymerase chain reactionen_US
dc.subjectprotein blood levelen_US
dc.subjectrespiratory distressen_US
dc.subjectsedationen_US
dc.subjectsedimentation rateen_US
dc.subjectsynchronized intermittent mandatory ventilationen_US
dc.subjecttachypneaen_US
dc.subjecttracheostomyen_US
dc.titleA case report: Successful management of pulmonary aspergillosis associated with COVID ? 19 ARDSen_US
dc.typearticleen_US
dc.departmentAmasya Üniversitesien_US
dc.identifier.volume39en_US
dc.identifier.issue2en_US
dc.identifier.startpage563en_US
dc.identifier.endpage565en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-85142013909en_US
dc.identifier.doi10.52142/omujecm.39.2.51
dc.department-tempErgül, D.F., Department of Intensive Care, University of Amasya, Sabuncuoğlu Şerafeddin Training and Research Hospital, Amasya, Turkey; Boran, M., Department of Intensive Care, University of Amasya, Sabuncuoğlu Şerafeddin Training and Research Hospital, Amasya, Turkeyen_US
dc.authorscopusid56638585800
dc.authorscopusid57217935893


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster